Physician profile
Perla Ibrahim
NPI 1558136051
$3,072.85
in general payments reported to CMS, 2019-2025
7 companies · $2,520 in 2025
The $2,520 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $553 · 2025: $2,520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,727 · Food and Beverage: $1,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,726.64 |
| Food and Beverage | $1,346.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $2,268.28 | 2024-2025 | Travoprost Intraocular Implant - Idose, Radius Xr, Istent Infinite |
| Biotissue Holdings INC. | $267.42 | 2024 | |
| Sun Pharmaceutical Industries INC. | $249.87 | 2025 | |
| Sight Sciences, INC. | $145.21 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Tarsus Pharmaceuticals, INC. | $78.64 | 2024 | Xdemvy |
| Bausch & Lomb Americas INC. | $53.81 | 2024-2025 | Miebo, Xiidra |
| Lkc Technologies, INC. | $9.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perla Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.